Nuveen Asset Management, LLC Grifols Sa Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.62 - $18.94 $2.35 Million - $2.68 Million	-141,671 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$15.15 - $19.78 $4,999 - $6,527	330 Added 0.23%	141,671 $2.45 Million
Q3 2020 Nov 16, 2020	BUY	$15.4 - $20.16 $860,444 - $1.13 Million	55,873 Added 65.37%	141,341 $2.45 Million
Q2 2020 Aug 14, 2020	SELL	$18.24 - $21.45 $1,076 - $1,265	-59 Reduced 0.07%	85,468 $1.56 Million
Q1 2020 May 14, 2020	SELL	$16.28 - $25.63 $3,142 - $4,946	-193 Reduced 0.23%	85,527 $1.72 Million
Q4 2019 Feb 14, 2020	SELL	$19.57 - $23.52 $22,916 - $27,541	-1,171 Reduced 1.35%	85,720 $2 Million
Q3 2019 Nov 14, 2019	SELL	$19.85 - $22.76 $19,274 - $22,099	-971 Reduced 1.11%	86,891 $1.74 Million
Q2 2019 Aug 15, 2019	BUY	$17.59 - $21.1 $1.55 Million - $1.85 Million	87,862 New	87,862 $1.85 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.